Lion Corporation TSE:4912
Lion : Notice Regarding Transfer of Consolidated Subsidiaries (Transfer of Shares of Two Subsidiaries in the Chemical Products Business)
Source: MarketScreener
February 12, 2026 Company Name: Lion Corporation Representative: Masayuki Takemori,
Representative Director, President and Executive Officer
Code Number: 4912 Prime Market of Tokyo Stock Exchange
Notice Regarding Transfer of Consolidated Subsidiaries (Transfer of Shares of Two Subsidiaries in the Chemical Products Business)
Lion Corporation herein announces the decision reached at today's Board of Directors meeting to transfer ownership of all shares of the Lion Group consolidated subsidiary Lion Specialty Chemicals Co., Ltd. (hereinafter, LSC) and its subsidiary PT. IPPOSHA INDONESIA (hereinafter, IPI) to AP88 Co., Ltd. (hereinafter, AP88), a special purpose company supported by a fund serviced by Advantage Partners, Inc., and has signed a share transfer agreement.
Purpose of Transfer
Lion Group is working to strengthen its business portfolio in order to realize "Strengthening Profitability", the core theme of our medium-term management plan, Vision2030 2nd STAGE, launched in 2025.
Under this plan, we have positioned the Chemical Products business as a target for structural reform, thoroughly considering available options for sustainable growth and development in the midst of a market environment undergoing major changes. As a result, it has been decided that allowing the two subsidiaries to pursue flexible and bold business strategies under Advantage Partners, Inc., which holds an extensive track record in numerous carve-out transactions, would enable further growth and development. Accordingly, we have decided to enter into this share transfer agreement.
Details of the Transfer
LSC
(As of December 31, 2025)
(1)
Name
Lion Specialty Chemicals Co., Ltd.
(2)
Location
1-3-28, Kuramae, Taito-ku, Tokyo
(3)
Representative
Masanori Nikaido, President and Chief Executive Officer
(4)
Business
Manufacture and sale of chemical agents, industrial chemicals,
chemicals for household use, agrochemicals, food additives, etc.
(5)
Capital
¥400 million
(6)
Date of establishment
November 25, 1923
(7)
Operating results for the most recent fiscal year
Fiscal year end
December 31, 2025
Revenue (net sales)
¥26.9 billion
(8)
Major shareholders
and shareholding ratios (Prior to transfer)
Lion Corporation: 100%
Capital
relationships
Lion Corporation holds 100% of the company's
shares.
(9)
Relationships with Lion Corporation
Personal
relationships
113 employees, including five of the company's
full-time directors, are Lion personnel.
Business relationships
Lion Corporation has a business relationship with the company, including the sale and purchase of raw materials and the lending and
borrowing of funds.
IPI
(As of December 31, 2025)
(1)
Name
PT. IPPOSHA INDONESIA
(2)
Location
Jalan Inspeksi, Cakung Drain Timur No.1 Jakarta Timur 13910,
Indonesia
(3)
Representative
Hiroki Okabe, President Director
(4)
Business
Sale of chemical products
(5)
Capital
US$750,000
(6)
Date of establishment
July 27, 2011
(7)
Operating results for the most recent fiscal year
Fiscal year end
December 31, 2025
Revenue (net sales)
US$4 million
(8)
Major shareholders and shareholding ratios
(Prior to transfer)
LSC: 90%
Lion Corporation: 10%
Capital
relationships
Lion Corporation holds 10% and LSC holds
90% of the company's shares.
(9)
Relationships with Lion
Corporation
Personal
relationships
One of the subsidiary's full-time directors is a
Lion employee.
Business
relationships
None
Overview of the Transferee
(As of February 12, 2026)
(1)
Name
AP88 Co., Ltd.
(2)
Location
17F Toranomon Towers Office, 4-1-28 Toranomon, Minato-ku
Tokyo
(3)
Representative
Takashi Nishimura, President
(4)
Business
Management consulting; acquisition, holding, management and trading of marketable securities, etc.
(5)
Capital
¥5,000
(6)
Date of establishment
February 2, 2026
(7)
Major shareholders
and shareholding ratios
AP88 Holdings Co., Ltd.: 100%
Capital
relationships
None
(8)
Relationships with Lion Corporation
Personal
relationships
None
Business
relationships
None
Status of
relationships
None
Shares to be Transferred, Transfer Price and Shareholdings before and after Transfer
LSC
(1)
Shares held before
transfer
5,000,000 (100% of voting rights)
(2)
Shares to be
transferred
5,000,000 (100% of voting rights)
(3)
Shares held after
transfer
0 (0% of voting rights)
IPI
(1)
Shares held before
transfer
10 (10% of voting rights)
(2)
Shares to be
transferred
10 (10% of voting rights)
(3)
Shares held after
transfer
0 (0% of voting rights)
Transfer Price
The amount will be determined with ¥18.9 billion as the basis, with adjustments made for net interest-bearing liabilities and working capital, etc.
Schedule
(1)
Resolution of the Board
of Directors
February 12, 2026 (today)
(2)
Conclusion of the
acquisition agreement
February 12, 2026 (today)
(3)
Delivery of shares
June 30, 2026 (tentative)
Impact on Business Performance
Upon completion of this transaction, LSC and IPI will no longer be consolidated subsidiaries of Lion as of June 30, 2026. This transaction will impact the consolidated results of the Lion Group and has already been factored into the forecast for the fiscal year ending December 31, 2026 published today.